Why Peptide Therapy Needs a Physician (Not a Research Vendor)
A research-chemical vendor can ship you a vial. It cannot screen you for the conditions that make a peptide unsafe, check it against your other medications, calibrate the dose to your situation, or tell you when a peptide is the wrong choice. Those are medical decisions, and they are the part of peptide therapy a vendor structurally cannot do. Here is what a prescribing physician actually adds.
In this article
Key Takeaways
- A research-chemical vendor can ship a vial but cannot make the medical decisions peptide therapy requires: contraindication screening, drug-interaction checks, dose calibration, and peptide selection.
- Growth-hormone-secretagogue peptides raise IGF-1, which is why an active cancer, pregnancy, or certain medications change whether a peptide should be prescribed at all. A physician screens for this; a vendor does not.
- The physician guarantees the decision (is this peptide right for you); the pharmacy guarantees the vial (sterility and potency). They are two different jobs, and you want both.
- A prescription carries medical accountability and a real medical record. A research-chemical purchase carries neither, which means no recourse if something goes wrong.
- At PeRx the medical work is concentrated at the prescribing decision plus a renewal check-in each 100-day cycle, after a 5-minute assessment with no labs required to start.
The Short Answer
The physician is the part you cannot buy in a vial
Peptide therapy has two halves. One is the product: a sterile, accurately dosed vial. The other is the decision: whether this peptide, at this dose, is right for this person. A research-chemical vendor can sell you the first half. Only a licensed prescriber can do the second. This guide is about that second half, because it is the part most people underestimate and the part that actually protects you.
What a Vendor Cannot Do
The research-peptide market is good at one thing: getting a molecule into a vial and shipping it to your door. That is a logistics problem, and the better suppliers solve it competently. What no vendor can solve, because it is not their job and they are not licensed to do it, is the clinical question underneath the purchase.
When you buy a research chemical, the transaction assumes you already know the peptide is safe for you, that it will not collide with your other medications, that your dose is correct, and that this peptide is even the right tool for your goal. A vendor has no way to verify any of that, and the "Not for Human Use" label exists precisely so they never have to. The decision is offloaded entirely onto you, usually without you realizing a decision was skipped.
A prescribing physician exists to make that decision with you. The work is not glamorous and it is mostly invisible when it goes well, which is part of why it gets undervalued. It looks like a few minutes of reviewing an intake form. What it actually is: a trained filter standing between you and a medication that could be a poor fit for reasons you would have no way to anticipate.
The Four Decisions a Physician Makes
Strip away the paperwork and a prescribing review comes down to four judgments. None of them can be made by the person selling the vial, and most of them cannot be safely made by the patient alone.
| The decision | What it involves | What happens without it | |
|---|---|---|---|
| Is it safe for you | Is this peptide safe for you | Screening your history for the conditions that make a given peptide a bad idea: active or recent cancer for anything that raises IGF-1, pregnancy and breastfeeding, uncontrolled chronic disease. | You take a peptide that is contraindicated for a condition you have, with no one having checked. |
| Drug interactions | Will it collide with your medications | Reviewing your full medication list. Growth-hormone-secretagogue peptides matter alongside diabetes medication; others matter alongside blood-pressure or hormone therapy. | An interaction you did not know to look for, identified too late or not at all. |
| Right dose | What dose is right for you | Calibrating a starting dose to your size, goals, and history rather than copying a forum protocol written for someone else. | A generic dose that is too high, too low, or simply guessed. |
| Right peptide | Is this even the right peptide | Matching the peptide to the actual goal. The peptide a patient asks for is sometimes not the one that fits their situation best. | Months spent on the wrong tool because no one questioned the original assumption. |
The IGF-1 example, concretely
Growth-hormone-secretagogue peptides such as CJC-1295, Ipamorelin, Sermorelin, and Tesamorelin work by raising growth hormone, which raises IGF-1. For most healthy adults that is the intended effect. For someone with an active or recently treated cancer, raising IGF-1 is a reason to pause and reconsider, because IGF-1 is a growth signal. A patient browsing a research-peptide site has no prompt to think about this. A prescriber asks about it before writing the order. That single question is the kind of thing physician review is for. See the general safety overview for more on how peptide risk is assessed.
The Value of Being Told No
Here is a thing a vendor will never do: decline the sale because the product is wrong for you. Their incentive runs the other way. A prescribing physician can, and a good one does. Being told "this is not the right peptide for what you are describing" or "you should hold off until this other issue is addressed" is not a failure of the service. It is the service working.
This is the cleanest way to see the difference between a transaction and a clinical relationship. A vendor optimizes for the sale. A prescriber is professionally and legally accountable for the decision, which means they carry a duty the vendor does not. When the answer should be no, only one of them is structurally able to say it.
Accountability and recourse
A prescription creates a medical record and a licensed professional who is accountable for the decision. A research-chemical purchase creates neither. If a research vial is contaminated, under-dosed, or wrong for you, there is no provider who reviewed it and no record of what you took. That gap matters most in exactly the moments you hope never happen.
How Physician Review Works at PeRx
The point of physician oversight is not to make access harder. It is to put the medical decision in the right hands without adding friction that does not earn its place. At PeRx that means the clinical work is concentrated where it changes outcomes, and stripped everywhere it does not.
What the process actually looks like
Step 1
You complete a 5-minute health assessment covering your goals, history, and current medications. No labs are required to start, and there is no in-person visit.
Step 2
A licensed provider reviews your intake. This is where the four decisions happen: safety screening, interaction check, dose calibration, and confirming the peptide fits your goal.
Step 3
If appropriate, the provider prescribes your protocol and it is compounded at a 503A pharmacy. Vials ship ready to use, refrigerated, so there is no patient-side mixing.
Step 4
You manage your routine dosing. At the end of each 100-day prescription cycle, a brief renewal check-in with your provider opens the next window. The medical touchpoints are the prescribing decision and the renewal, not constant supervision.
The doctors who review PeRx prescriptions are named and credentialed, not an anonymous "medical team." You can see who they are on our team page. That transparency is part of the point: the person making the decision about your medication should be someone you can actually identify. Two related reads if you are weighing the decision: how peptide therapy is priced, and the research vs prescription comparison that covers the pharmacy side of quality.
Frequently Asked Questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
Pinealon, PE-22-28 & Selank Guide (2026)
Three peptides, three layers of brain support. Pinealon restores sleep architecture through pineal gland regulation. PE-22-28 drives neurogenesis by blocking the TREK-1 potassium channel. Selank calms anxiety through GABA modulation without sedation or dependence. Together they rebuild, grow, and protect neural tissue from three independent angles.
Can You Legally Get CJC-1295/Ipamorelin in 2026? FDA Status
The short answer is no. CJC-1295 and Ipamorelin are not FDA-approved drugs. They are compounded medications, prescribed by licensed providers and prepared by regulated pharmacies. Here is what that actually means for you, how it compares to FDA-approved peptides, and why the distinction matters less than most people think.
Sermorelin: FDA-Approved 1997-2008 (2026 Status)
Sermorelin has a unique regulatory history. It was FDA-approved in 1997 as Geref Diagnostic for testing pituitary function, and its therapeutic form (Geref) was used for pediatric growth hormone deficiency. Then the manufacturer discontinued it in 2008. Today Sermorelin is only available as a compounded medication. Here is the full story.
Start with a provider, not a vendor
Take our 5-minute health assessment. A licensed provider reviews every intake, screens for safety and interactions, and prescribes only what fits your situation. No labs required to start. Approved orders ship overnight, refrigerated, ready to use.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.